118 related articles for article (PubMed ID: 38070755)
1. Inhibition of SIRT7 promotes STAT1 activation and STAT1-dependent signaling in hepatocellular carcinoma.
Dong L; Wei X; Yu L; Li Y; Chen L
Cell Signal; 2024 Feb; 114():111005. PubMed ID: 38070755
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol Promoted Interferon-α-Induced Growth Inhibition and Apoptosis of SMMC7721 Cells by Activating the SIRT/STAT1.
Yang Z; Meng Q; Zhao Y; Han R; Huang S; Li M; Wu X; Cai W; Wang H
J Interferon Cytokine Res; 2018 Jun; 38(6):261-271. PubMed ID: 29762078
[TBL] [Abstract][Full Text] [Related]
3. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
4. SIRT7 regulates hepatocellular carcinoma response to therapy by altering the p53-dependent cell death pathway.
Zhao J; Wozniak A; Adams A; Cox J; Vittal A; Voss J; Bridges B; Weinman SA; Li Z
J Exp Clin Cancer Res; 2019 Jun; 38(1):252. PubMed ID: 31196136
[TBL] [Abstract][Full Text] [Related]
5. Dichotomal functions of phosphorylated and unphosphorylated STAT1 in hepatocellular carcinoma.
Ma B; Chen K; Liu P; Li M; Liu J; Sideras K; Sprengers D; Biermann K; Wang W; IJzermans JNM; Cao W; Kwekkeboom J; Peppelenbosch MP; Pan Q
J Mol Med (Berl); 2019 Jan; 97(1):77-88. PubMed ID: 30456450
[TBL] [Abstract][Full Text] [Related]
6. Aspirin enhances IFN-α-induced growth inhibition and apoptosis of hepatocellular carcinoma via JAK1/STAT1 pathway.
Li T; Dong ZR; Guo ZY; Wang CH; Tang ZY; Qu SF; Chen ZT; Li XW; Zhi XT
Cancer Gene Ther; 2013 Jun; 20(6):366-74. PubMed ID: 23703473
[TBL] [Abstract][Full Text] [Related]
7. SIRT7 promotes Hippo/YAP activation and cancer cell proliferation in hepatocellular carcinoma via suppressing MST1.
Gu Y; Ding C; Yu T; Liu B; Tang W; Wang Z; Tang X; Liang G; Peng J; Zhang X; Li Z
Cancer Sci; 2024 Apr; 115(4):1209-1223. PubMed ID: 38288904
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological and molecular analysis of SIRT7 in hepatocellular carcinoma.
Yanai M; Kurata M; Muto Y; Iha H; Kanao T; Tatsuzawa A; Ishibashi S; Ikeda M; Kitagawa M; Yamamoto K
Pathology; 2020 Aug; 52(5):529-537. PubMed ID: 32586688
[TBL] [Abstract][Full Text] [Related]
9. Interferon-gamma inhibits interferon-alpha signalling in hepatic cells: evidence for the involvement of STAT1 induction and hyperexpression of STAT1 in chronic hepatitis C.
Radaeva S; Jaruga B; Kim WH; Heller T; Liang TJ; Gao B
Biochem J; 2004 Apr; 379(Pt 1):199-208. PubMed ID: 14690454
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA PVT1 inhibits interferon-α mediated therapy for hepatocellular carcinoma cells by interacting with signal transducer and activator of transcription 1.
Ding H; Liu J; Liu B; Zeng Y; Chen P; Su Y
Biochem Biophys Res Commun; 2018 Jun; 500(4):973-980. PubMed ID: 29715456
[TBL] [Abstract][Full Text] [Related]
11. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW
Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745
[TBL] [Abstract][Full Text] [Related]
12. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells.
Wonganan O; He YJ; Shen XF; Wongkrajang K; Suksamrarn A; Zhang GL; Wang F
Toxicol Appl Pharmacol; 2017 Dec; 336():31-39. PubMed ID: 29031523
[TBL] [Abstract][Full Text] [Related]
13. LncRNA AIRN influences the proliferation and apoptosis of hepatocellular carcinoma cells by regulating STAT1 ubiquitination.
Cai H; Zheng Y; Wen Z; Yang Y; Yang S; Zhang Q
Arch Pharm Res; 2021 Apr; 44(4):414-426. PubMed ID: 33759138
[TBL] [Abstract][Full Text] [Related]
14. Smurf1 protein negatively regulates interferon-γ signaling through promoting STAT1 protein ubiquitination and degradation.
Yuan C; Qi J; Zhao X; Gao C
J Biol Chem; 2012 May; 287(21):17006-17015. PubMed ID: 22474288
[TBL] [Abstract][Full Text] [Related]
15. ERK is a negative feedback regulator for IFN-γ/STAT1 signaling by promoting STAT1 ubiquitination.
Zhang Y; Chen Y; Liu Z; Lai R
BMC Cancer; 2018 May; 18(1):613. PubMed ID: 29855346
[TBL] [Abstract][Full Text] [Related]
16. CYP2E1-dependent upregulation of SIRT7 is response to alcohol mediated metastasis in hepatocellular carcinoma.
Zhang C; Zhao J; Zhao J; Liu B; Tang W; Liu Y; Huang W; Weinman SA; Li Z
Cancer Gene Ther; 2022 Dec; 29(12):1961-1974. PubMed ID: 35902730
[TBL] [Abstract][Full Text] [Related]
17. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of SIRT7 overcomes sorafenib acquired resistance by suppressing ERK1/2 phosphorylation via the DDX3X-mediated NLRP3 inflammasome in hepatocellular carcinoma.
Kim Y; Jung KY; Kim YH; Xu P; Kang BE; Jo Y; Pandit N; Kwon J; Gariani K; Gariani J; Lee J; Verbeek J; Nam S; Bae SJ; Ha KT; Yi HS; Shong M; Kim KH; Kim D; Jung HJ; Lee CW; Kim KR; Schoonjans K; Auwerx J; Ryu D
Drug Resist Updat; 2024 Mar; 73():101054. PubMed ID: 38277756
[TBL] [Abstract][Full Text] [Related]
19. MiR-21-5p promotes sorafenib resistance and hepatocellular carcinoma progression by regulating SIRT7 ubiquitination through USP24.
Hu Z; Zhao Y; Mang Y; Zhu J; Yu L; Li L; Ran J
Life Sci; 2023 Jul; 325():121773. PubMed ID: 37187452
[TBL] [Abstract][Full Text] [Related]
20. IRF1 supports DNA binding of STAT1 by promoting its phosphorylation.
Zenke K; Muroi M; Tanamoto KI
Immunol Cell Biol; 2018 Nov; 96(10):1095-1103. PubMed ID: 29893425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]